Abbott Laboratories (NYSE: ABT) is set to announce its fourth-quarter earnings on January 22, 2026, prior to the market opening. Analysts anticipate that the...
A federal court has dismissed a significant case against Abbott Laboratories, which could influence over 1,400 similar lawsuits regarding its formula for preterm infants....